Literature DB >> 23352788

The peripartum management of a patient with glutaric aciduria type 1.

Unyime S Ituk1, Terrence K Allen, Ashraf S Habib.   

Abstract

The management of cesarean delivery for a parturient with placenta previa at 36 weeks' gestation and glutaric aciduria type 1 is presented. The management goal was to prevent encephalopathic crisis by ensuring adequate caloric intake with dextrose infusion and to provide carnitine supplementation and adequate anesthesia.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23352788     DOI： 10.1016/j.jclinane.2012.06.023

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN： 0952-8180            Impact factor:   9.452


  4 in total

Review 1.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

2.  Two Uneventful Pregnancies in a Woman with Glutaric Aciduria Type 1.

Authors:  Karolina M Stepien; Gregory M Pastores; Una Hendroff; Ciara McCormick; Patricia Fitzimons; Naveed Khawaja; Ingrid Borovickova; Eileen P Treacy
Journal:  JIMD Rep       Date:  2018-01-03

Review 3.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 4.  Anesthetic management of patients with carnitine deficiency or a defect of the fatty acid β-oxidation pathway: A narrative review.

Authors:  Ho Kyung Yu; Seong-Ho Ok; Sunmin Kim; Ju-Tae Sohn
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.